More recently, the role of BCL3 in solid tumors started to be elucidated, and its overexpression, observed in breast and nasopharyngeal tumors, seems to be induced by NF-κB activation and EBV latent genes, respectively (17–19). The gene discussed is BCL3; the disease is nasopharyngeal neoplasm.